A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Compound Glycyrrhizin Capsules Combined with a Topical Corticosteroid in Adults with Chronic Eczema
Table 3
Adverse event incidence.
Adverse event n (%)
Total N = 193
Control N = 99
Treated N = 94
Edema of both lower limbs
3 (1.6)
0 (0)
3 (3.2)
Hypokalemia
1 (0.5)
0 (0)
1 (1.1)
Facial edema
1 (0.5)
1 (1.0)
0 (0)
Hematuria
1 (0.5)
1 (1.0)
0 (0)
Trunk and limb pruritus
1 (0.5)
0 (0)
1 (1.1)
Renal contusion
1 (0.5)
0 (0)
1 (1.1)
Blood pressure elevation
2 (1.0)
0 (0)
2 (2.1)
Transaminase elevation
1 (0.5)
1 (1.0)
0 (0)
Adverse events include abnormal clinical laboratory test results, physical examination, and physiological test results.